J Neurosci. 2025 Oct 16. pii: e1372252025. [Epub ahead of print]
Yong-Lin He,
Liang Niu,
Chen Wang,
Zhi-Peng Liao,
Kai Liu,
Shuo Gao,
Ai-Chao Du,
Wei-Guo Liu,
Juan Jia,
Yu-Bo Zhang,
Hang Yin,
Guo-Qiang Yuan,
Ya-Wen Pan.
Glioblastoma (GBM), the most aggressive tumor in the adult central nervous system, remains a major therapeutic challenge due to its high recurrence and resistance to conventional therapies. Recent evidence underscores the pivotal role of glioma stem cells (GSCs) in driving these malignant features. In this study, using intracranial xenograft models established in four-week-old male BALB/c nude mice and patient-derived primary glioma stem cells, we uncover a critical function of the chromatin assembly factor subunit Chaf1b in sustaining the stemness of GSCs and modulating the tumor immune microenvironment. We show that Chaf1b is markedly overexpressed in high-grade gliomas and GSC populations. Genetic silencing of Chaf1b led to a significant reduction in GSC self-renewal capacity and tumorigenicity, both in vitro and in intracranial xenograft models. Mechanistically, Chaf1b was found to upregulate IL-33 secretion, thereby promoting microglial M2 polarization and activating the PI3K/AKT signaling pathway-effects that were reversible upon IL-33 neutralization. These findings position Chaf1b as a key mediator of GBM aggressiveness and suggest it as a promising target for disrupting the stem-immune axis in glioblastoma.Significance Statement This study reveals the critical role of the chromatin assembly factor Chaf1b in glioma stem cells (GSCs). We found that Chaf1b is significantly upregulated in subventricular zone-positive (SVZ⁺) glioblastoma (GBM) patients and in their derived GSCs. Functional experiments demonstrated that Chaf1b knockdown markedly inhibits GSC proliferation, self-renewal, and tumorigenicity in vivo. Mechanistically, Chaf1b induces IL-33 secretion from GSCs, promotes microglial polarization toward the immunosuppressive M2 phenotype, and activates the PI3K/AKT signaling pathway. These processes collectively reshape the immune microenvironment, enhance GSC stemness, and drive GBM progression. This study systematically elucidates the pivotal role of Chaf1b in stemness maintenance and immune modulation of GSCs, highlighting its potential as a therapeutic target for GBM.